A 5,2 Intermittent Fasting Meal Replacement Diet for Adults with Diabetes
A randomized trial compared 5:2 intermittent fasting with metformin and empagliflozin in diabetic adults. Results showed improved glycemic control with reduced HbA1c levels and fasting glucose, suggesting potential benefits for diabetes management.
Read original article
The study conducted a randomized clinical trial to evaluate the effects of a 5:2 intermittent fasting meal replacement diet on glycemic control in adults with diabetes. Participants were assigned to the intermittent fasting plan, metformin, or empagliflozin groups. The results showed a reduction in hemoglobin A1c levels in the intermittent fasting group compared to the other groups. Additionally, the percentage of patients achieving target HbA1c levels was higher in the intermittent fasting group. Fasting plasma glucose concentrations also decreased in the intermittent fasting group. The study included analyses of patients with overweight or obesity as well. The findings suggest that the 5:2 intermittent fasting meal replacement diet could be a beneficial approach for improving glycemic control in adults with diabetes. Further research and longer-term studies may be needed to confirm these results and explore the sustainability of this dietary intervention.
Related
Walking to combat back pain
A study by Macquarie University's Spinal Pain Research Group reveals regular walking reduces low back pain recurrence. Combining walking with education sessions proves effective and cost-efficient in preventing back pain long-term.
FDA, Industry Actions End Sales of PFAS Used in Food Packaging
The FDA discontinues sales of PFAS in food packaging to reduce dietary exposure. Manufacturers commit to removing PFAS from items like fast-food wrappers, enhancing consumer safety and health protection through ongoing research and collaboration.
Study identifies first drug therapy for sleep apnea
Researchers at UC San Diego found tirzepatide, a diabetes drug, promising for treating sleep apnea. The study on 469 participants worldwide showed reduced breathing interruptions, weight loss, and improved heart health. Tirzepatide may offer a new OSA treatment option.
Skipping Breakfast Is Associated with Risk of Gastrointestinal Cancers (2023)
Habitual breakfast skipping increases GI cancer risk, as per the Kailuan Cohort Study with 62,746 participants. No significant mediation effects were found despite exploring potential factors like BMI and CRP.
High-fat diet, microbiome-gut-brain axis signaling, and anxiety in rats
Researchers studied male rats on a high-fat diet (HFD) to analyze its impact on gut microbiome, brain gene expression, and anxiety behavior. HFD led to reduced microbiome diversity, altered gene expression, and increased anxiety-like behaviors.
0 commentsRelated
Walking to combat back pain
A study by Macquarie University's Spinal Pain Research Group reveals regular walking reduces low back pain recurrence. Combining walking with education sessions proves effective and cost-efficient in preventing back pain long-term.
FDA, Industry Actions End Sales of PFAS Used in Food Packaging
The FDA discontinues sales of PFAS in food packaging to reduce dietary exposure. Manufacturers commit to removing PFAS from items like fast-food wrappers, enhancing consumer safety and health protection through ongoing research and collaboration.
Study identifies first drug therapy for sleep apnea
Researchers at UC San Diego found tirzepatide, a diabetes drug, promising for treating sleep apnea. The study on 469 participants worldwide showed reduced breathing interruptions, weight loss, and improved heart health. Tirzepatide may offer a new OSA treatment option.
Skipping Breakfast Is Associated with Risk of Gastrointestinal Cancers (2023)
Habitual breakfast skipping increases GI cancer risk, as per the Kailuan Cohort Study with 62,746 participants. No significant mediation effects were found despite exploring potential factors like BMI and CRP.
High-fat diet, microbiome-gut-brain axis signaling, and anxiety in rats
Researchers studied male rats on a high-fat diet (HFD) to analyze its impact on gut microbiome, brain gene expression, and anxiety behavior. HFD led to reduced microbiome diversity, altered gene expression, and increased anxiety-like behaviors.